ArticleCancer biology & therapy2014

Inhibition of STAT3 activity re-activates anti-tumor immunity but fails to restore the immunogenicity of tumor cells in a B-cell lymphoma model.

Yang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.